Will Mauldin, Ph.D. — Chairman, CEO, and Co‑founder at RIVANNA — discusses the future of spinal needle guidance in a healthcare system still dominated by fee-for-service models. As the industry moves toward value-based care, RIVANNA is leading the way with ultrasound-driven solutions that enhance patient safety, reduce complications, and lower costs.
Delivering true innovation means improving both outcomes and economics. Follow us and stay tuned for updates!